The Board of Directors has decided to postpone the application for changing trading list to NASDAQ OMX
The decision means that the planned change of trading venue for SyntheticMR's share to NASDAQ OMX Stockholm will be postponed to the future. The company has recently made a CEO change and the resources will be focused on the business operations to further establish the company's products in the global market.For additional information, please contact Fredrik Jeppsson, CFO and Head of Investor Realtions, SyntheticMR AB, +46 72 303 13 39 or Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging